Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works

Cancer statistics, 2019

Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works

GSVA: gene set variation analysis for microarray and RNA-Seq data

Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · see citing works

The Molecular Signatures Database Hallmark Gene Set Collection

Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · see citing works

FactoMineR : An R Package for Multivariate Analysis

Lê, S., Josse, J., & Husson, F. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i01 · Cited by 12,103 · see citing works

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · see citing works

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · see citing works

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368 · see citing works

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,055 · see citing works

Adjusting batch effects in microarray expression data using empirical Bayes methods

Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658 · see citing works

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,719 · see citing works

The Reactome pathway Knowledgebase

Fabregat, A., Sidiropoulos, K., Garapati, P. V., Gillespie, M. E., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,568 · see citing works

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257 · see citing works

The biology and management of non-small cell lung cancer

Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891 · see citing works

COSMIC: the Catalogue Of Somatic Mutations In Cancer

Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,822 · see citing works

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,442 · see citing works

xCell: digitally portraying the tissue cellular heterogeneity landscape

Aran, D., Hu, Z., & Butte, A. J. (2017) · Genome Biology · doi:10.1186/s13059-017-1349-1 · Cited by 4,397 · see citing works

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,133 · see citing works

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,869 · see citing works

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515 · see citing works

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Mermel, C. H., Schumacher, S. E., Hill, B. A., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,468 · see citing works

Defining a Cancer Dependency Map

Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276 · see citing works

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201 · see citing works

Discovery and saturation analysis of cancer genes across 21 tumour types

Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · see citing works

CTLA-4 Control over Foxp3 ⁺ Regulatory T Cell Function

Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956 · see citing works

mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models

Scrucca, L., Fop, M., Murphy, T. B., & Adrian, E. R. (2016) · The R Journal · doi:10.32614/rj-2016-021 · Cited by 2,914 · see citing works

TGF-β-induced epithelial to mesenchymal transition

Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804 · see citing works

The Reactome Pathway Knowledgebase

Fabregat, A., Jupe, S., Matthews, L. R., Sidiropoulos, K., Gillespie, M. E., Garapati, P. V., Haw, R., Jassal, B., Korninger, F., May, B., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1132 · Cited by 2,798 · see citing works

Somatic mutations affect key pathways in lung adenocarcinoma

Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681 · see citing works

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1090 · Cited by 2,324 · see citing works

Comprehensive Characterization of Cancer Driver Genes and Mutations

Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,316 · see citing works

Metagenes and molecular pattern discovery using matrix factorization

Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183 · see citing works

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180 · see citing works

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136 · see citing works

Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data

Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · see citing works

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 1,978 · see citing works

Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer

Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964 · see citing works

The Reactome pathway knowledgebase

Croft, D., Mundo, A. F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1102 · Cited by 1,889 · see citing works

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · see citing works

Proteogenomics connects somatic mutations to signalling in breast cancer

CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676 · see citing works

Strelka2: fast and accurate calling of germline and somatic variants

Kim, S., Scheffler, K., Halpern, A. L., Bekritsky, M. A., Noh, E., Källberg, M., Chen, X., Kim, Y., Beyter, D., Krusche, P., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0051-x · Cited by 1,643 · see citing works

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B. W., Latham, V. M., & Sullivan, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1122 · Cited by 1,636 · see citing works

Lung cancer in never smokers — a different disease

Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2190 · Cited by 1,601 · see citing works

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597 · see citing works

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,589 · see citing works

A flexible R package for nonnegative matrix factorization

Gaujoux, R., & Seoighe, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-367 · Cited by 1,554 · see citing works

A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics

Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A., Amini, B., Andersen, E., Andersson, A., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,543 · see citing works

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Key, N. S., Khorana, A. A., Kuderer, N. M., Bohlke, K., Lee, A. Y. Y., Arcelus, J. I., Wong, S. L., Balaban, E. P., Flowers, C. R., Francis, C. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01461 · Cited by 1,511 · see citing works

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

Jurtz, V. I., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,476 · see citing works

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429 · see citing works

RET, ROS1 and ALK fusions in lung cancer

Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320 · see citing works

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200 · see citing works

WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit

Wang, J., Vasaikar, S. V., Shi, Z., Greer, M., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx356 · Cited by 1,161 · see citing works

Characterizing the cancer genome in lung adenocarcinoma

Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105 · see citing works

MS-GF+ makes progress towards a universal database search tool for proteomics

Kim, S., & Pevzner, P. A. (2014) · Nature Communications · doi:10.1038/ncomms6277 · Cited by 1,098 · see citing works

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029 · see citing works

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Lai, Z., Markovets, A. A., Ahdesmaki, M. J., Chapman, B., Hofmann, O., McEwen, R. K., Johnson, J., Dougherty, B. A., Barrett, J. C., & Dry, J. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw227 · Cited by 971 · see citing works

Lung cancer in never smokers – A review

Couraud, S., Zalcman, G., Milleron, B. J., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 962 · see citing works

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Chen, Y.-N. P., LaMarche, M. J., Chan, H. M., Fekkes, P., Garcia-Fortanet, J., Acker, M. G., Antonakos, B., Chen, C. H.-T., Chen, Z., Cooke, V. G., et al. (2016) · Nature · doi:10.1038/nature18621 · Cited by 925 · see citing works

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 915 · see citing works

Functional normalization of 450k methylation array data improves replication in large cancer studies

Fortin, J.-P., Labbe, A., Lemire, M., Zanke, B. W., Hudson, T. J., Fertig, E. J., Greenwood, C. M. T., & Hansen, K. D. (2014) · Genome biology · doi:10.1186/s13059-014-0503-2 · Cited by 893 · see citing works

DGIdb 3.0: a redesign and expansion of the drug–gene interaction database

Cotto, K. C., Wagner, A. H., Feng, Y.-Y., Kiwala, S., Coffman, A. C., Spies, G., Wollam, A., Spies, N. C., Griffith, O. L., & Griffith, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1143 · Cited by 888 · see citing works

Colonic epithelial cell diversity in health and inflammatory bowel disease

Parikh, K., Antanaviciute, A., Fawkner-Corbett, D., Jagielowicz, M., Aulicino, A., Lagerholm, B. C., Davis, S. A., Kinchen, J. W., Chen, H. H., Alham, N. K., et al. (2019) · Nature · doi:10.1038/s41586-019-0992-y · Cited by 866 · see citing works

Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis

Kim, H., & Park, H. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm134 · Cited by 865 · see citing works

Integrative clinical genomics of metastatic cancer

Robinson, D. R., Wu, Y.-M., Lonigro, R. J., Vats, P., Cobain, E., Everett, J., Cao, X., Rabban, E., Kumar-Sinha, C., Raymond, V., et al. (2017) · Nature · doi:10.1038/nature23306 · Cited by 863 · see citing works

Reactome pathway analysis: a high-performance in-memory approach

Fabregat, A., Sidiropoulos, K., Viteri, G., Forner, O., Marín-García, P., Arnau, V., D’Eustachio, P., Stein, L. D., & Hermjakob, H. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1559-2 · Cited by 859 · see citing works

KIF5B-RET fusions in lung adenocarcinoma

Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834 · see citing works

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2960 · Cited by 816 · see citing works

Respiratory epithelial cells orchestrate pulmonary innate immunity

Whitsett, J. A., & Alenghat, T. (2014) · Nature Immunology · doi:10.1038/ni.3045 · Cited by 804 · see citing works

OptiType: precision HLA typing from next-generation sequencing data

Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., & Kohlbacher, O. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu548 · Cited by 778 · see citing works

Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity*

Fang, D.-X., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 774 · see citing works

Muc5b is required for airway defence

Roy, M. G., Livraghi-Butrico, A., Fletcher, A. A., McElwee, M. M., Evans, S. E., Boerner, R. M., Alexander, S. N., Bellinghausen, L. K., Song, A. S., Petrova, Y. M., et al. (2014) · Nature · doi:10.1038/nature12807 · Cited by 764 · see citing works

Lung Cancer in Never Smokers: A Review

Subramanian, J., & Govindan, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8015 · Cited by 705 · see citing works

A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries

Fisher, S., Barry, A. J., Abreu, J., Minie, B., Nolan, J., Delorey, T. M., Young, G., Fennell, T. J., Allen, A., Ambrogio, L., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-1-r1 · Cited by 683 · see citing works

A Compendium of Mutational Signatures of Environmental Agents

Kucab, J. E., Zou, X., Morganella, S., Joel, M., Nanda, A. S., Nagy, E., Gomez, C., Degasperi, A., Harris, R., Jackson, S. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.001 · Cited by 660 · see citing works

Protein-tyrosine phosphatases and cancer

Östman, A., Hellberg, C. B., & Böhmer, F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1837 · Cited by 657 · see citing works

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Li, S., Shen, D., Shao, J., Crowder, R. J., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 623 · see citing works

Structural basis of Keap1 interactions with Nrf2

Canning, P., Sorrell, F. J., & Bullock, A. N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.034 · Cited by 605 · see citing works

BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis

Wiel, C., Le Gal, K., Ibrahim, M. X., Jahangir, C. A., Kashif, M., Yao, H., Ziegler, D. V., Xu, X., Ghosh, T., Mondal, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.005 · Cited by 579 · see citing works

Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1

Lignitto, L., LeBoeuf, S. E., Homer, H., Jiang, S., Askenazi, M., Karakousi, T. R., Pass, H. I., Bhutkar, A. J., Tsirigos, A., Ueberheide, B., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.003 · Cited by 573 · see citing works

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

Gao, Q.-S., Liang, W.-W., Foltz, S., Mutharasu, G., Jayasinghe, R., Cao, S., Liao, W.-W., Reynolds, S., Wyczalkowski, M., Yao, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.050 · Cited by 557 · see citing works

The KEAP1–NRF2 System in Cancer

Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527 · see citing works

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Weinert, B. T., Narita, T., Satpathy, S., Srinivasan, B., Hansen, B. K., Scholz, C. W., Hamilton, W. B., Zucconi, B. E., Wang, W., Liu, W. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.033 · Cited by 514 · see citing works

A Genomics-Based Classification of Human Lung Tumors

Thomas, R. K., Buettner, R., & Wolf, J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006802 · Cited by 508 · see citing works

Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer

Wang, Y., Kuan, P. J., Xing, C., Cronkhite, J. T., Torres, F., Rosenblatt, R. L., DiMaio, J. M., Kinch, L. N., Grishin, N. V., & Garcia, C. K. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.010 · Cited by 496 · see citing works

Proteogenomic Characterization of Endometrial Carcinoma

Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485 · see citing works

Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry

Mertins, P., Tang, L. C., Krug, K., Clark, D. J., Gritsenko, M., Chen, L., Clauser, K. R., Clauss, T. R., Shah, P., Gillette, M. A., et al. (2018) · Nature Protocols · doi:10.1038/s41596-018-0006-9 · Cited by 482 · see citing works

SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database

Jewison, T., Su, Y., Disfani, F. M., Liang, Y., Knox, C., Maciejewski, A., Poelzer, J., Huynh, J., Zhou, Y. L., Arndt, D., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1067 · Cited by 476 · see citing works

Dynamic profiling of the protein life cycle in response to pathogens

Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460 · see citing works

Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway

Aronheim, A., Engelberg, D., Li, N., Al-Alawi, N., Schlessinger, J., & Karin, M. (1994) · Cell · doi:10.1016/0092-8674(94)90271-2 · Cited by 458 · see citing works

Targeting the IDO1 pathway in cancer: from bench to bedside

Liu, M., Wang, X., Wang, L., Ma, X., Gong, Z., Zhang, S., & Li, Y. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0644-y · Cited by 449 · see citing works

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

de Almeida, L. G. P., Sakabe, N. J., deOliveira, A. R., da Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y., Chua, R., Gurung, S., Gnjatic, S., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 436 · see citing works

Regulation of the p300 HAT domain via a novel activation loop

Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural &amp; Molecular Biology · doi:10.1038/nsmb740 · Cited by 423 · see citing works

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors

Kim, J., Mouw, K. W., Polak, P. P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Allen, E. M. V., D’Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 402 · see citing works

Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.

Bennett, A. M., Tang, T. L., Sugimoto, S., Walsh, C. T., & Neel, B. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7335 · Cited by 397 · see citing works

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction

Hillig, R. C., Sautier, B., Schroeder, J., Moosmayer, D., Hilpmann, A., Stegmann, C. M., Werbeck, N. D., Briem, H., Boemer, U., Weiske, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812963116 · Cited by 388 · see citing works

Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Chen, Y.-J., Roumeliotis, T. I., Chang, Y.-H., Chen, C.-T., Han, C.-L., Lin, M.-H., Chen, H.-W., Chang, G.-C., Chang, Y.-L., Wu, C.-T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.012 · Cited by 382 · see citing works

Smoking and Lung Cancer: The Role of Inflammation

Walser, T. C., Cui, X., Yanagawa, J., Lee, J. M., Heinrich, E., Lee, G., Sharma, S., & Dubinett, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-100th · Cited by 381 · see citing works

SMPDB: The Small Molecule Pathway Database

Frolkis, A., Knox, C., Lim, E. L., Jewison, T., Law, V., Hau, D., Liu, P., Gautam, B., Ly, S., Guo, A. C., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1002 · Cited by 376 · see citing works

Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Gautschi, O. P., Milia, J., Filleron, T., Wolf, J., Carbone, D. P., Owen, D. H., Camidge, D. R., Narayanan, V., Doebele, R. C., Besse, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.9352 · Cited by 364 · see citing works

A Curated Resource for Phosphosite-specific Signature Analysis

Krug, K., Mertins, P., Zhang, B., Hornbeck, P. V., Raju, R., Ahmad, R., Szucs, M. J., Mundt, F., Forestier, D., Jané‐Valbuena, J., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000943 · Cited by 329 · see citing works

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Kim, J., Hu, Z., Cai, L., Li, K., Choi, E., Faubert, B., Bezwada, D., Rodriguez-Canales, J., Villalobos, P., Lin, Y.-F., et al. (2017) · Nature · doi:10.1038/nature22359 · Cited by 325 · see citing works

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

Chen, G., Gharib, T. G., Huang, C.-C., Thomas, D. G., Shedden, K., Taylor, J. M. G., Kardia, S. L. R., Misek, D. E., Giordano, T. J., Iannettoni, M. D., et al. (2002) · PubMed · Cited by 317 · see citing works

SnapShot: Immune Checkpoint Inhibitors

Abril-Rodríguez, G., & Ribas, A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.010 · Cited by 311 · see citing works

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition

Cloonan, N., Brown, M. K., Steptoe, A. L., Wani, S., Chan, W. L., Forrest, A. R., Kolle, G., Gabrielli, B., & Grimmond, S. M. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-r127 · Cited by 304 · see citing works

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

Wilkerson, M. D., Yin, X., Walter, V., Zhao, N., Cabanski, C. R., Hayward, M. C., Miller, C. R., Socinski, M. A., Parsons, A. M., Thorne, L. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036530 · Cited by 300 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells

Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296 · see citing works

The incidence of venous thromboembolism among patients with primary lung cancer

Chew, H. K., Davies, A. M., Wun, T., HARVEY, D., Zhou, H., & WHITE, R. H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02908.x · Cited by 292 · see citing works

i-Tracker: For quantitative proteomics using iTRAQ™

Shadforth, I., Dunkley, T. P. J., Lilley, K. S., & Bessant, C. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-145 · Cited by 281 · see citing works

Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease

Pastva, A. M., Wright, J. R., & Williams, K. L. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-018aw · Cited by 277 · see citing works

Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence

Tan, V. Y. F., & Févotte, C. (2012) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2012.240 · Cited by 271 · see citing works

Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling

Lu, W., Gong, D., Bar-Sagi, D., & Cole, P. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00369-0 · Cited by 268 · see citing works

Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1

Fukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 265 · see citing works

p120-Catenin Mediates Inflammatory Responses in the Skin

Pérez‐Moreno, M., Davis, M. A., Wong, E., Pasolli, H. A., Reynolds, A. B., & Fuchs, E. V. (2006) · Cell · doi:10.1016/j.cell.2005.11.043 · Cited by 264 · see citing works

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

Aceto, N., Sausgruber, N., Brinkhaus, H., Gaidatzis, D., Martiny‐Baron, G., Mazzarol, G., Confalonieri, S., Quarto, M., Hu, G., Balwierz, P. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2645 · Cited by 263 · see citing works

Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers

Chapman, A. M., Sun, K., Ruestow, P., Cowan, D. M., & Madl, A. K. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.10.010 · Cited by 260 · see citing works

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

Kasar, S. N., Kim, J., Improgo, R., Tiao, G., Polak, P. P., Haradhvala, N. J., Lawrence, M. S., Kieżun, A., Fernandes, S. M., Bahl, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9866 · Cited by 248 · see citing works

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer

Shimizu, K., Nakata, M., Hirami, Y., Yukawa, T., Maeda, A., & Tanemoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60fd7 · Cited by 244 · cited 2× · see citing works

Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation

Matozaki, T., Murata, Y., Saito, Y., Okazawa, H., & Ohnishi, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01257.x · Cited by 240 · see citing works

Coupling and coordination in gene expression processes: a systems biology view

Komili, S., & Silver, P. A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2223 · Cited by 218 · see citing works

Detecting multiple change-points in the mean of Gaussian process by model selection

Lebarbier, É. (2004) · Signal Processing · doi:10.1016/j.sigpro.2004.11.012 · Cited by 213 · see citing works

Topoisomerase IIα in chromosome instability and personalized cancer therapy

Chen, T., Sun, Y. K., Ji, P., Kopetz, S., & Zhang, W. (2014) · Oncogene · doi:10.1038/onc.2014.332 · Cited by 207 · see citing works

Grb2 signaling in cell motility and cancer

Giubellino, A., Burke, T. R., & Bottaro, D. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.1021 · Cited by 206 · see citing works

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity

Nayak, A., Dodagatta-Marri, E., Tsolaki, A. G., & Kishore, U. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00131 · Cited by 206 · see citing works

A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation

Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J., & Raynal, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410012200 · Cited by 205 · see citing works

Claudin-18–mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis

Zhou, B., Flodby, P., Luo, J., Castillo, D. R., Liu, Y., Yu, F., McConnell, A. M., Varghese, B. A., Li, G., Chimge, N., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci90429 · Cited by 182 · see citing works

Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow

Svinkina, T., Gu, H., Silva, J. C., Mertins, P., Qiao, J., Fereshetian, S., Jaffe, J. D., Kuhn, E. W., Udeshi, N. D., & Carr, S. A. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.047555 · Cited by 179 · see citing works

A cross-package Bioconductor workflow for analysing methylation array data

Maksimovic, J., Phipson, B., & Oshlack, A. (2017) · F1000Research · doi:10.12688/f1000research.8839.3 · Cited by 179 · see citing works

Protein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data

Wang, X., Slebos, R. J. C., Wang, D., Halvey, P. J., Tabb, D. L., Liebler, D. C., & Zhang, B. (2012) · Journal of Proteome Research · doi:10.1021/pr200766z · Cited by 173 · see citing works

PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs

Prahallad, A., Heynen, G. J. J. E., Germano, G., Willems, S. M., Evers, B., Vecchione, L., Gambino, V., Lieftink, C., Beijersbergen, R. L., Di Nicolantonio, F., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.037 · Cited by 168 · see citing works

Large-scale profiling of microRNAs for The Cancer Genome Atlas

Chu, A., Robertson, G., Brooks, D., Mungall, A. J. J., Birol, İ., Coope, R., Ma, Y. P., Jones, S. J. M., & Marra, M. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv808 · Cited by 165 · see citing works

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation

Romano, G., Acunzo, M., Garofalo, M., Leva, G. D., Cascione, L., Zanca, C., Bolon, B. N., Condorelli, G., & Croce, C. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207917109 · Cited by 164 · see citing works

Regulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2

Cunnick, J. M., Meng, S., Ren, Y., Desponts, C., Wang, H., Djeu, J. Y., & Wu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110547200 · Cited by 162 · see citing works

<i>customProDB</i>: an R package to generate customized protein databases from RNA-Seq data for proteomics search

Wang, X., & Zhang, B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt543 · Cited by 162 · see citing works

DNA methylation–based immune response signature improves patient diagnosis in multiple cancers

Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., den Eynden, G. V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91095 · Cited by 157 · see citing works

Pharmacological targeting of RAS: recent success with direct inhibitors

O’Bryan, J. P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.021 · Cited by 153 · see citing works

Absolute Proteome and Phosphoproteome Dynamics during the Cell Cycle of Schizosaccharomyces pombe (Fission Yeast)

Carpy, A., Krug, K., Graf, S., Koch, A., Popic, S., Hauf, S., & Maček, B. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035824 · Cited by 146 · see citing works

Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities

Ganapathy‐Kanniappan, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.002 · Cited by 141 · see citing works

CD73–Adenosine: A Next-Generation Target in Immuno-Oncology

Allard, D., Allard, B., Gaudreau, P.-O., Chrobák, P., & Stagg, J. (2016) · Immunotherapy · doi:10.2217/imt.15.106 · Cited by 140 · see citing works

Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis

Wen, B., Li, K., Zhang, Y., & Zhang, B. (2020) · Nature Communications · doi:10.1038/s41467-020-15456-w · Cited by 139 · see citing works

Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9

Scanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 137 · see citing works

A cross-package Bioconductor workflow for analysing methylation array data

Maksimovic, J., Phipson, B., & Oshlack, A. (2016) · F1000Research · doi:10.12688/f1000research.8839.2 · Cited by 132 · see citing works

The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma

Tufo, G., Jones, A. W. E., Wang, Z., Hamelin, J., Tajeddine, N., Esposti, D. D., Martel, C., Boursier, C., Gallerne, C., Migdal, C., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.193 · Cited by 131 · see citing works

Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium

Salomonis, N., Dexheimer, P. J., Omberg, L., Schroll, R., Bush, S., Huo, J. S., Schriml, L. M., Sui, S. H., Keddache, M. A., Mayhew, C. N., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.006 · Cited by 128 · see citing works

PDV: an integrative proteomics data viewer

Li, K., Vaudel, M., Zhang, B., Ren, Y., & Wen, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty770 · Cited by 126 · see citing works

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056226 · Cited by 118 · see citing works

A cross-package Bioconductor workflow for analysing methylation array data

Maksimovic, J., Phipson, B., & Oshlack, A. (2016) · F1000Research · doi:10.12688/f1000research.8839.1 · Cited by 117 · see citing works

Microscaled proteogenomic methods for precision oncology

Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C. L., Singh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14381-2 · Cited by 113 · see citing works

Rapid and deep-scale ubiquitylation profiling for biology and translational research

Udeshi, N. D., Mani, D. R., Satpathy, S., Fereshetian, S., Gasser, J. A., Svinkina, T., Olive, M. E., Ebert, B. L., Mertins, P., & Carr, S. A. (2020) · Nature Communications · doi:10.1038/s41467-019-14175-1 · Cited by 112 · see citing works

Recruitment of Phosphorylated NPM1 to Sites of DNA Damage through RNF8-Dependent Ubiquitin Conjugates

Koike, A., Nishikawa, H., Wu, W., Okada, Y., Venkitaraman, A. R., & Ohta, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0382 · Cited by 110 · see citing works

Oncogenic KRAS‐induced interleukin‐8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non‐small cell lung cancer

Sunaga, N., Imai, H., Shimizu, K., Shames, D. S., Kakegawa, S., Girard, L., Sato, M., Kaira, K., Ishizuka, T., Gazdar, A. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26164 · Cited by 99 · see citing works

Matrix Metalloproteinase 12 Overexpression in Lung Epithelial Cells Plays a Key Role in Emphysema to Lung Bronchioalveolar Adenocarcinoma Transition

Qu, P., Du, H., Wang, X., & Yan, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0577 · Cited by 99 · see citing works

PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterationsPreprint

Wen, B., Wang, X., & Zhang, B. (2019) · Genome Research · doi:10.1101/gr.235028.118 · Cited by 97 · see citing works

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk

Salerno, E. P., Bedognetti, D., Mauldin, I. S., Deacon, D. H., Shea, S. M., Pinczewski, J., Obeid, J. M., Coukos, G., Wang, E., Gajewski, T. F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1240857 · Cited by 96 · see citing works

ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES

Sokolov, A., Paull, E., & Stuart, J. M. (2015) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814749411_0037 · Cited by 95 · see citing works

The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis

Ducray, S. P., Natarajan, K., Garland, G. D., Turner, S. D., & Egger, G. (2019) · Cancers · doi:10.3390/cancers11081074 · Cited by 95 · see citing works

Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis

Tang, D. L., Liu, J. J., Rundle, A., Neslund-Dudas, C. M., Savera, A. T., Bock, C. H., Nock, N. L., Yang, J. J., & Rybicki, B. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0973 · Cited by 92 · see citing works

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

Lochhead, P. J., Imamura, Y., Morikawa, T., Kuchiba, A., Yamauchi, M., Liao, X., Qian, Z. R., Nishihara, R., Wu, K., Meyerhardt, J. A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.021 · Cited by 91 · see citing works

β-Catenin Contributes to Lung Tumor Development Induced by EGFR Mutations

Nakayama, S., Sng, N., Carretero, J., Welner, R. S., Hayashi, Y., Yamamoto, M., Tan, A. J., Yamaguchi, N., Yasuda, H., Li, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0184 · Cited by 91 · see citing works

Heme oxygenase inhibition in cancers: possible tools and targets

Podkalicka, P., Mucha, O., Józkowicz, A., Dulak, J., & Łoboda, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73879 · Cited by 89 · see citing works

Mammalian Son of Sevenless Guanine Nucleotide Exchange Factors: Old Concepts and New Perspectives

Rojas, J. M., Oliva, J. L., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911408078 · Cited by 88 · see citing works

Genetic Deletion of RALA and RALB Small GTPases Reveals Redundant Functions in Development and Tumorigenesis

Peschard, P., McCarthy, A., Leblanc-Dominguez, V., Yeo, M., Guichard, S., Stamp, G., & Marshall, C. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.09.013 · Cited by 82 · see citing works

Oncofetal protein IMP3

Jiang, Z., Lohse, C. M., Chu, P. G., Wu, C., Woda, B. A., Rock, K. L., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23484 · Cited by 82 · see citing works

The role of Ral A in epidermal growth factor receptor-regulated cell motility.

Gildea, J. J., Harding, M. A., Seraj, M. J., Gulding, K. M., & Theodorescu, D. (2002) · PubMed · Cited by 81 · see citing works

Carcinogenicity of the Chlorination Disinfection By-Product MX

McDonald, T., & Komulainen, H. (2005) · Journal of Environmental Science and Health Part C · doi:10.1080/10590500500234988 · Cited by 80 · see citing works

SnapShot: Ras Signaling

Cully, M., & Downward, J. (2008) · Cell · doi:10.1016/j.cell.2008.06.020 · Cited by 79 · see citing works

Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma

Jariwala, N. H., Rajasekaran, D., Mendoza, R. G., Shen, X., Siddiq, A., Akiel, M., Robertson, C. L., Subler, M. A., Windle, J. J., Fisher, P. B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0298 · Cited by 78 · see citing works

Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK*

Kamioka, Y., Yasuda, S., Fujita, Y., Aoki, K., & Matsuda, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135517 · Cited by 76 · see citing works

Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia

Loriot, A. E., Boon, T., & Smet, C. D. (2003) · International Journal of Cancer · doi:10.1002/ijc.11104 · Cited by 75 · see citing works

Genetic Variants of Surfactant Proteins A, B, C, and D in Bronchopulmonary Dysplasia

Pavlovic, J., Papagaroufalis, C., Xanthou, M., Liu, W., Fan, R., Thomas, N. J., Apostolidou, I., Papathoma, E., Megaloyianni, E., DiAngelo, S. L., et al. (2006) · Disease Markers · doi:10.1155/2006/817805 · Cited by 71 · see citing works

A Comparison of Nine Confidence Intervals for a Poisson Parameter When the Expected Number of Events is ≤ 5

Barker, L. E. (2002) · The American Statistician · doi:10.1198/000313002317572736 · Cited by 70 · see citing works

Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.

Vogel, W. F., & Ullrich, A. (1996) · PubMed · Cited by 69 · see citing works

High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer

Yang, C., Peng, P., Li, L., Shao, M., Zhao, J., Wang, L., Duan, F., Song, S., Wu, H., Zhang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep39044 · Cited by 67 · see citing works

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer

Zhang, W., Zhang, J., Zhang, Z., Guo, Y., Wu, Y., Wang, R., Wang, L., Mao, S., & Yao, X. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.012 · Cited by 65 · see citing works

Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway

Hosgood, H. D., Menashe, I., Shen, M., Yeager, M., Yuenger, J., Rajaraman, P., He, X., Chatterjee, N., Caporaso, N. E., Zhu, Y. L., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn178 · Cited by 64 · see citing works

MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21

Chen, C., Lu, Z., Yang, J., Hao, W.-C., Qin, Y., Wang, H., Xie, C., & Xie, R. (2016) · Cancer Medicine · doi:10.1002/cam4.863 · Cited by 64 · see citing works

Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival

Fahrmann, J. F., Grapov, D., Phinney, B. S., Stroble, C., DeFelice, B. C., Rom, W. N., Gandara, D. R., Zhang, Y., Fiehn, O., Pass, H. I., et al. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9132-y · Cited by 64 · see citing works

Identification of Tcf-4 as a transcriptional target of p53 signalling

Rother, K., Johne, C., Spiesbach, K., Haugwitz, U., Tschöp, K., Wasner, M., Klein‐Hitpaß, L., Möröy, T., Mössner, J., & Engeland, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207464 · Cited by 63 · see citing works

Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

Fujise, N., Nanashima, A., Taniguchi, Y., Matsuo, S., Hatano, K., Matsumoto, Y., Tagawa, Y., & Ayabe, H. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00088-4 · Cited by 62 · see citing works

TAK -ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy

Santoro, R., Carbone, C., Piro, G., Chiao, P. J., & Melisi, D. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.004 · Cited by 61 · see citing works

GSTP1 methylation in cancer: a liquid biopsy biomarker?

Gurioli, G., Martignano, F., Salvi, S., Costantini, M., Gunelli, R., & Casadio, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0703 · Cited by 61 · see citing works

miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway

Shi, D.-M., Bian, X., Qin, C., & Wu, W. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s152611 · Cited by 61 · see citing works

Ral GTPases in tumorigenesis: Emerging from the shadows

Kashatus, D. F. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.020 · Cited by 60 · see citing works

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics

Foerster, S., Kacprowski, T., Dhople, V. M., Hammer, E., Herzog, S., Saafan, H., Bien-Möller, S., Albrecht, M., Völker, U., & Ritter, C. A. (2013) · PROTEOMICS · doi:10.1002/pmic.201300154 · Cited by 60 · see citing works

Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases

Menn, G. L., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 60 · see citing works

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability

Zhao, W., Lü, D., Liu, L., Cai, J., Zhou, Y., Yang, Y., Zhang, Y., & Zhang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21280 · Cited by 59 · see citing works

PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma

Lei, B., Qi, W., Zhao, Y., Li, Y., Liu, S., Xu, X., Chen, Z., Wan, L., & Shen, H. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.07.026 · Cited by 57 · see citing works

Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives

Daily, K., Ho Sui, S. J., Schriml, L. M., Dexheimer, P. J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.30 · Cited by 57 · see citing works

Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells

Takei, N., Yoneda, A., Sakai, K., Kosaka, M., Minomi, K., & Tamura, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09976-7 · Cited by 57 · see citing works

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer

Dou, F., Li, H., Zhu, M., Liang, L., Zhang, Y., Yi, J., & Zhang, Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0791-2 · Cited by 56 · see citing works

Towards a general-purpose foundation model for computational pathology

Chen, R. J., Ding, T., Lu, M. Y., Williamson, D. F. K., Jaume, G., Song, A. H., Chen, B., Zhang, A., Shao, D., Shaban, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02857-3 · Cited by 1,560 · see citing works

Modulation of cellular processes by histone and non-histone protein acetylation

Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 975 · see citing works

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

Tan, A. C., & Tan, D. S. W. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01626 · Cited by 782 · see citing works

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578 · see citing works

Neutrophils in cancer carcinogenesis and metastasis

Xiong, S., Dong, L., & Cheng, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01187-y · Cited by 570 · see citing works

Applications of multi‐omics analysis in human diseases

Chen, C., Wang, J., Pan, D., Wang, X., Xu, Y., Yan, J., Wang, L., Yang, X., Yang, M., & Liu, G. (2023) · MedComm · doi:10.1002/mco2.315 · Cited by 545 · see citing works

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 532 · see citing works

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442 · see citing works

Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Chen, Y.-J., Roumeliotis, T. I., Chang, Y.-H., Chen, C.-T., Han, C.-L., Lin, M.-H., Chen, H.-W., Chang, G.-C., Chang, Y.-L., Wu, C.-T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.012 · Cited by 382 · see citing works

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Dong, L., Lu, D., Chen, R., Lin, Y., Zhu, H., Zhang, Z., Cai, S., Cui, P., Song, G., Rao, D., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.12.006 · Cited by 400 · see citing works

Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities

Müller-Dott, S., Tsirvouli, E., Vazquez, M., Flores, R. R., Badia-i-Mompel, P., Fallegger, R., Türei, D., Lægreid, A., & Saez-Rodriguez, J. (2023) · bioRxiv · doi:10.1093/nar/gkad841 · Cited by 352 · see citing works

A proteogenomic portrait of lung squamous cell carcinoma

Satpathy, S., Krug, K., Beltran, P. M. J., Savage, S. R., Petralia, F., Kumar‐Sinha, C., Dou, Y., Reva, B. A., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 375 · see citing works

Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

Leader, A. M., Grout, J. A., Maier, B. B., Nabet, B. Y., Park, M. D., Tabachnikova, A., Chang, C., Walker, L. A., Lansky, A., Bérichel, J. L., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.009 · Cited by 356 · see citing works

Sex disparities matter in cancer development and therapy

Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B., & Haupt, Y. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00348-y · Cited by 333 · see citing works

Machine learning for multi-omics data integration in cancer

Cai, Z., Poulos, R. C., Liu, J., & Zhong, Q. (2022) · iScience · doi:10.1016/j.isci.2022.103798 · Cited by 341 · see citing works

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., Krek, A., Ma, W., Zhu, Y., Ji, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.044 · Cited by 317 · see citing works

Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes

Heo, Y. J., Hwa, C., Lee, G.-H., Park, J.-M., & An, J.-Y. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0042 · Cited by 294 · see citing works

Genetic and non-genetic clonal diversity in cancer evolution

Black, J. R., & McGranahan, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00336-2 · Cited by 287 · see citing works

Pathological implication of protein post-translational modifications in cancer

Pan, S., & Chen, R. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101097 · Cited by 272 · see citing works

Proteogenomic data and resources for pan-cancer analysis

Li, Y., Dou, Y., Leprevost, F. D. V., Geffen, Y., Calinawan, A. P., Aguet, F., Akiyama, Y., Anand, S. K., Birger, C., Cao, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.06.009 · Cited by 260 · see citing works

Cancer proteogenomics: current impact and future prospects

Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229 · see citing works

A high-stringency blueprint of the human proteome

Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210 · see citing works

Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways

Zhang, Y., Chen, F., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30342-3 · Cited by 216 · see citing works

Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies

Liu, Q., Zhang, J., Guo, C., Wang, M., Wang, C., Yan, Y., Sun, L., Wang, D., Zhang, L., Yu, H., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.004 · Cited by 217 · see citing works

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Geffen, Y., Anand, S. K., Akiyama, Y., Yaron, T. M., Song, Y., Johnson, J. L., Govindan, A., Babur, Ö., Li, Y., Huntsman, E. M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.013 · Cited by 210 · see citing works

MCT4-Dependent Lactate Secretion Suppresses Antitumor Immunity in LKB1-Deficient NSCLC

Qian, Y., Galán‐Cobo, A., Guijarro, I., Dang, M., Molkentine, D. P., Poteete, A., Zhang, F., Wang, Q., Wang, J., Parra, E. R., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2023.05.015 · Cited by 204 · see citing works

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H., & Lowy, D. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.055 · Cited by 190 · see citing works

Targeting pan-essential genes in cancer: Challenges and opportunities

Chang, L., Ruiz, P. A., Ito, T., & Sellers, W. R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.008 · Cited by 183 · see citing works

Technological advances in cancer immunity: from immunogenomics to single‐cell analysis and artificial intelligence

Xu, Y., Su, G.-H., Ma, D., Xiao, Y., Shao, Z.-M., & Jiang, Y.-Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00729-7 · Cited by 163 · see citing works

Immune Escape Mechanisms in Non Small Cell Lung Cancer

Anichini, A., Perotti, V., Sgambelluri, F., & Mortarini, R. (2020) · Cancers · doi:10.3390/cancers12123605 · Cited by 169 · see citing works

Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting

Liu, W., Xie, L., He, Y.-H., Wu, Z.-Y., Liu, L.-X., Bai, X., Deng, D.-X., Xu, X., Liao, L.-D., Lin, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25202-5 · Cited by 165 · see citing works

Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models

Hong, R., Liu, W., DeLair, D., Razavian, N., & Fenyö, D. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100400 · Cited by 154 · see citing works

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

Pataskar, A., Champagne, J., Nagel, R., Kenski, J. C. N., Laos, M., Michaux, J., Pak, H. S., Bleijerveld, O. B., Mordente, K., Navarro, J. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04499-2 · Cited by 146 · see citing works

PTM-Shepherd: Analysis and Summarization of Post-Translational and Chemical Modifications From Open Search Results

Geiszler, D., Kong, A. T., Avtonomov, D. M., Yu, F., Leprevost, F. D. V., & Nesvizhskii, A. I. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir120.002216 · Cited by 147 · see citing works

A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population

Qu, Y., Feng, J., Wu, X., Bai, L., Xu, W., Zhu, L., Liu, Y., Xu, F., Zhang, X., Yang, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29577-x · Cited by 139 · see citing works

Mass spectrometry‐based high‐throughput proteomics and its role in biomedical studies and systems biology

Messner, C. B., Demichev, V., Wang, Z., Hartl, J., Kustatscher, G., Mülleder, M., & Ralser, M. (2022) · PROTEOMICS · doi:10.1002/pmic.202200013 · Cited by 133 · see citing works

RNA-SeQC 2: efficient RNA-seq quality control and quantification for large cohorts

Graubert, A., Aguet, F., Ravi, A., Ardlie, K., & Getz, G. A. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab135 · Cited by 132 · see citing works

Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma

Nie, M., Yao, K., Zhu, X., Chen, N., Xiao, N., Wang, Y., Peng, B., Yao, L., Li, P., Zhang, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26685-y · Cited by 126 · see citing works

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

Kacen, A., Javitt, A., Kramer, M. P., Morgenstern, D., Tsaban, T., Shmueli, M. D., Teo, G. C., Leprevost, F. D. V., Barnea, E., Yu, F., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01464-2 · Cited by 128 · see citing works

Quantitative Proteomics Using Isobaric Labeling: A Practical Guide

Chen, X., Sun, Y., Zhang, T., Shu, L., Roepstorff, P., & Yang, F. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.012 · Cited by 126 · see citing works

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

Kramer, M. H., Zhang, Q., Sprung, R. W., Day, R. B., Erdmann-Gilmore, P., Li, Y., Xu, Z., Helton, N., George, D. R., Mi, Y., et al. (2022) · Blood · doi:10.1182/blood.2022016033 · Cited by 122 · see citing works

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers

Devarakonda, S., Li, Y., Rodrigues, F. M., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01691 · Cited by 120 · see citing works

Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives

Guo, H., Zhang, J., Qin, C., Yan, H., Liu, T., Hu, H., Tang, S., Tang, S., & Zhou, H. (2022) · Cells · doi:10.3390/cells11203200 · Cited by 118 · see citing works

Molecular classification of hormone receptor-positive HER2-negative breast cancer

Jin, X., Zhou, Y.-F., Ma, D., Zhao, S., Lin, C., Xiao, Y., Fu, T., Liu, C., Chen, Y., Xiao, W.-X., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01507-7 · Cited by 117 · see citing works

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Lehtiö, J., Arslan, T., Siavelis, I., Pan, Y., Socciarelli, F., Berkovska, O., Umer, H. M., Mermelekas, G., Pirmoradian, M., Jönsson, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00259-9 · Cited by 115 · see citing works

Pan-cancer proteogenomics connects oncogenic drivers to functional states

Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 114 · see citing works

Integrated proteogenomic characterization of glioblastoma evolution

Kim, K., Migliozzi, S., Koo, H., Hong, J.-H., Park, S. M., Kim, S., Kwon, H. J., Ha, S., Garofano, L., Oh, Y. T., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.015 · Cited by 111 · see citing works

Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

Yang, H., Sun, B., Fan, L., Ma, W., Xu, K., Hall, S. R. R., Wang, Z., Schmid, R. A., Peng, R., Marti, T. M., et al. (2022) · Theranostics · doi:10.7150/thno.69590 · Cited by 107 · see citing works

Moving pan-cancer studies from basic research toward the clinic

Chen, F., Wendl, M. C., Wyczalkowski, M. A., Bailey, M. H., Li, Y., & Ding, L. (2021) · Nature Cancer · doi:10.1038/s43018-021-00250-4 · Cited by 107 · see citing works

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

Liang, W.-W., Lu, R. J.-H., Jayasinghe, R. G., Foltz, S. M., Porta-Pardo, E., Geffen, Y., Wendl, M. C., Lazcano, R., Kolodziejczak, I., Song, Y., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.013 · Cited by 105 · see citing works

Personalized phosphoproteomics identifies functional signaling

Needham, E. J., Hingst, J. R., Parker, B. L., Morrison, K. R., Yang, G., Onslev, J., Kristensen, J. M., Højlund, K., Ling, N. X. Y., Oakhill, J. S., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01099-9 · Cited by 98 · see citing works

Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer

Li, R., Salehi‐Rad, R., Crosson, W. P., Momcilovic, M., Lim, R. J., Ong, S. L., Huang, Z. L., Zhang, T.-H., Abascal, J. W., Dumitras, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3564 · Cited by 97 · see citing works

Advances in Integrated Multi-omics Analysis for Drug-Target Identification

Du, P., Fan, R., Zhang, N., Wu, C., & Zhang, Y. (2024) · Biomolecules · doi:10.3390/biom14060692 · Cited by 97 · see citing works

Pan-cancer proteogenomics characterization of tumor immunity

Petralia, F., Ma, W., Yaron, T. M., Caruso, F. P., Tignor, N. L., Wang, J. M., Charytonowicz, D., Johnson, J. L., Huntsman, E. M., Marino, G. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.027 · Cited by 96 · see citing works

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors

Zhang, F., Zhang, Q., Zhu, J., Yao, B., Ma, C., Qiao, N., He, S., Ye, Z., Wang, Y., Han, R., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00736-5 · Cited by 90 · see citing works

Proteomics, Personalized Medicine and Cancer

Su, M., Zhang, Z., Zhou, L., Han, C., Huang, C., & Nice, E. C. (2021) · Cancers · doi:10.3390/cancers13112512 · Cited by 92 · see citing works

Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles

Upadhya, S. R., & Ryan, C. J. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100288 · Cited by 81 · see citing works

Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue

Guo, Y., Li, H., Chen, H., Li, Z., Ding, W., Wang, J., Yin, Y., Jin, L., Sun, S., Jing, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103639 · Cited by 74 · see citing works

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Soltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 76 · see citing works

Integration of Online Omics-Data Resources for Cancer Research

Das, T., Andrieux, G., Ahmed, M., & Chakraborty, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.578345 · Cited by 63 · see citing works

A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes

Wang, T.-Y., Liu, Q., Ren, Y., Alam, S. K., Wang, L., Zhu, Z., Hoeppner, L. H., Dehm, S. M., Cao, Q., & Yang, R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.028 · Cited by 74 · see citing works

Proteogenomics of glioblastoma associates molecular patterns with survival

Arad, G., Ofek, P., Yeini, E., Mardamshina, M., Danilevsky, A., Shomron, N., Grossman, R., Satchi‐Fainaro, R., & Geiger, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108787 · Cited by 74 · see citing works

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

Xu, K., Ma, J., Hall, S. R. R., Peng, R., Yang, H., & Yao, F. (2023) · Theranostics · doi:10.7150/thno.80184 · Cited by 75 · see citing works

Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS ‐ LKB1 co‐mutated lung cancer cells

Han, J. H., Kim, Y. K., Kim, H., Lee, J., Oh, M. J., Kim, M., Kim, K. H., Kim, K. H., Yoon, H. J., Lee, M., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12332 · Cited by 71 · see citing works

The Privatization Challenge: A Strategic, Legal, and Institutional Analysis of International Experience

Guislain, P. (1997) · Cited by 71 · see citing works

Digital profiling of gene expression from histology images with linearized attention

Pizurica, M., Zheng, Y., Carrillo‐Pérez, F., Noor, H., Yao, W., Wohlfart, C., Vladimirova, A., Kathleen Marchal, D., & Gevaert, O. (2024) · Nature Communications · doi:10.1038/s41467-024-54182-5 · Cited by 81 · see citing works

Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer

Dai, L.-J., Ma, D., Xu, Y.-Z., Li, M., Li, Y., Xiao, Y., Jin, X., Wu, S., Zhao, Y., Wang, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40715-x · Cited by 68 · see citing works

Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma

Luo, M., Zhou, Y., Gu, W.-M., Wang, C., Shen, N.-X., Dong, J.-K., Lei, H.-M., Tang, Y., Liang, Q., Zou, J.-H., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4074 · Cited by 66 · see citing works

Advancing precision oncology with AI-powered genomic analysis

Srivastava, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591696 · Cited by 72 · see citing works

Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer

Queiroz, A. L., Dantas, E., Ramsamooj, S., Murthy, A., Ahmed, M., Zunica, E. R. M., Liang, R. J., Murphy, J., Holman, C. D., Bare, C. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32135-0 · Cited by 66 · see citing works

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas

Tanaka, I., Daydé, D., Tai, M.-C., Mori, H., Solis, L. M., Tripathi, S. C., Fahrmann, J. F., Ünver, N., Parhy, G., Jain, R., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab183 · Cited by 65 · see citing works

Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies

Li, Y.-W., Dai, L.-J., Wu, X., Zhao, S., Xu, Y.-Z., Jin, X., Xiao, Y., Wang, Y., Lin, C., Zhou, Y.-F., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-4066 · Cited by 65 · see citing works

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues

Abelin, J. G., Bergstrom, E. J., Rivera, K. D., Taylor, H. B., Klaeger, S., Xu, C., Verzani, E. K., White, C. J., Woldemichael, H. B., Virshup, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37547-0 · Cited by 61 · see citing works

Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer

Campeanu, I. J., Jiang, Y., Liu, L., Pilecki, M., Najor, A., Cobani, E., Manning, M., Zhang, X. M., & Yang, Z.-Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-94019-5 · Cited by 62 · see citing works

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

Li, S., Correia, G. S. D. C., Wang, J., Manochakian, R., Zhao, Y., & Lou, Y. (2023) · Cancers · doi:10.3390/cancers15112899 · Cited by 62 · see citing works

Acute depletion of CTCF rewires genome-wide chromatin accessibility

Xu, B., Wang, H., Wright, S., Hyle, J. W., Zhang, Y., Shao, Y., Niu, M., Fan, Y., Rosikiewicz, W., Djekidel, M. N., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02466-0 · Cited by 57 · see citing works

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets

Pan, Y., Kadash-Edmondson, K. E., Wang, R., Phillips, J., Liu, S., Ribas, A., Aplenc, R., Witte, O. N., & Xing, Y. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.006 · Cited by 59 · see citing works

Multi-level attention graph neural network based on co-expression gene modules for disease diagnosis and prognosis

Xing, X., Yang, F., Li, H., Zhang, J., Zhao, Y., Gao, M., Huang, J., & Yao, J. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac088 · Cited by 58 · see citing works

The 2022 Report on the Human Proteome from the HUPO Human Proteome Project

Omenn, G. S., Lane, L., Overall, C. M., Pineau, C., Packer, N. H., Cristea, I. M., Lindskog, C., Weintraub, S. T., Orchard, S. E., Roehrl, M. H. A., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00498 · Cited by 60 · see citing works

A proteogenomics data-driven knowledge base of human cancer

Liao, Y., Savage, S. R., Dou, Y., Shi, Z., Yi, X., Jiang, W., Lei, J. T., & Zhang, B. (2023) · Cell Systems · doi:10.1016/j.cels.2023.07.007 · Cited by 56 · see citing works

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma

Jiang, L., Qin, J., Dai, Y., Zhao, S., Zhan, Q., Cui, P., Ren, L., Wang, X., Zhang, R., Gao, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02790-x · Cited by 59 · see citing works

The Circulating Proteome─Technological Developments, Current Challenges, and Future Trends

Geyer, P. E., Hornburg, D., Pernemalm, M., Hauck, S. M., Palaniappan, K. K., Albrecht, V., Dagley, L. F., Moritz, R. L., Yu, X., Edfors, F., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00586 · Cited by 57 · see citing works

Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy

Xing, X., Hu, E., Ouyang, J., Zhong, X., Wang, F., Liu, K., Cai, L., Zhou, Y., Wang, Y., Chen, G., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101315 · Cited by 55 · see citing works

STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC

Li, A., Wang, Y., Yu, Z., Tan, Z., He, L., Fu, S., Shi, M., Du, W., Luo, L., Li, Z., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.07.020 · Cited by 54 · see citing works

Prediction of brain metastasis development with DNA methylation signatures

Zuccato, J., Mamatjan, Y., Nassiri, F., Ajisebutu, A. A., Liu, J., Muazzam, A., Singh, O., Zhang, W., Voisin, M. R., Mirhadi, S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03286-y · Cited by 54 · see citing works

Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade

Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 54 · see citing works

Integrated multi-omics characterization of KRAS mutant colorectal cancer

Chong, W., Zhu, X., Ren, H., Ye, C., Xu, K., Wang, Z., Jia, S., Shang, L., Li, L., & Chen, H. (2022) · Theranostics · doi:10.7150/thno.73089 · Cited by 53 · see citing works

Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer

Huang, H., Yi, X., Wei, Q., Li, M., Cai, X., Lv, Y., Weng, L., Mao, Y., Fan, W., Zhao, M., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01766-w · Cited by 53 · see citing works

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes

Mirhadi, S., Tam, S., Li, Q., Moghal, N., Pham, N., Tong, J., Golbourn, B. J., Krieger, J. R., Taylor, P. P., Li, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29444-9 · Cited by 52 · see citing works

Integrated Lactylome Characterization Reveals the Molecular Dynamics of Protein Regulation in Gastrointestinal Cancers

Duan, Y., Zhan, H., Wang, Q., Li, B., Gao, H., Liu, D., Xu, Q., Gao, X., Liu, Z., Gao, P., et al. (2024) · Advanced Science · doi:10.1002/advs.202400227 · Cited by 51 · see citing works

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma

Tong, Y., Sun, M., Chen, L., Wang, Y., Yan, L., Li, L., Zhang, X., Cai, Y., Qie, J., Pang, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01384-3 · Cited by 51 · see citing works

VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms

Zhang, K., Zakeri, A., Alban, T. J., Dong, J., Ta, H. M., Zalavadia, A. H., Branicky, A., Zhao, H., Jurić, I., Husic, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113661 · Cited by 52 · see citing works

Mass spectrometry-based targeted proteomics for analysis of protein mutations

Lin, T.-T., Zhang, T., Kitata, R. B., Liu, T., Smith, R. D., Qian, W., & Shi, T.-J. (2021) · Mass spectrometry reviews (Print) · doi:10.1002/mas.21741 · Cited by 44 · see citing works

Lactobacillus acidophilus LA14 Alleviates Liver Injury

Lv, L., Yao, C., Ren, Y., Jiang, H., Wang, Q., Wang, K., Ren, S., Jiang, S., Xia, J., Li, S., et al. (2021) · mSystems · doi:10.1128/msystems.00384-21 · Cited by 49 · see citing works

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

Aldea, M. D., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J., Nikolaev, S. I., & André, F. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101642 · Cited by 51 · see citing works

Targeting KRAS mutant lung cancer: light at the end of the tunnel

Drosten, M., & Barbacid, M. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13168 · Cited by 47 · see citing works

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction

Li, S., Li, Y., Xu, Z., Xu, J., Chen, G., Guan, X., Pan, G.-Z., Hu, C., Dong, J., Du, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36462-8 · Cited by 46 · see citing works

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC

Javitt, A., Shmueli, M. D., Kramer, M. P., Kolodziejczyk, A. A., Cohen, I., Radomir, L., Sheban, D., Kamer, I., Litchfield, K., Bab-Dinitz, E., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00557-4 · Cited by 47 · see citing works

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer

Mota, I. A., Patrucco, E., Mastini, C., Mahadevan, N. R., Thai, T. C., Bergaggio, E., Cheong, T.-C., Leonardi, G. C., Atabay, E. K., Campisi, M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00591-2 · Cited by 47 · see citing works

Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma

Zhu, H.-W., Lin, Y.-P., Lu, D.-Y., Wang, S., Liu, Y., Dong, L.-Q., Meng, Q., Gao, J., Wang, Y., Song, N., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad167 · Cited by 40 · see citing works

Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures

Satpathy, S., Clark, N. M., Chen, Y., Hosseini, N., Chang, Y.-H., Hsiao, Y., Lei, J. T., Petralia, F., Chen, J., Geffen, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.011 · Cited by 22 · see citing works

A02 Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B. A., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.12.031 · Cited by 3 · see citing works

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Soltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 76 · see citing works

Abstract 5893: Comprehensive proteogenomic analysis and classification of lung adenocarcinoma

Soltis, A. R., Bateman, N. W., Conrads, T. P., Dalgard, C. L., Hu, H., Franks, T. J., Liu, J., Meerzaman, D. M., Petricoin, E. F., Chen, Q., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-5893

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

Xu, J., Zhang, C., Wang, X., Zhai, L., Ma, Y., Mao, Y., Qian, K., Sun, C., Liu, Z., Jiang, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.043 · Cited by 612 · see citing works